TY  - JOUR
AU  - Ramirez-Carracedo, Rafael
AU  - Tesoro, Laura
AU  - Hernández, Ignacio
AU  - Diez-Mata, Javier
AU  - Piñeiro,  David
AU  - Hernández Jiménez, Macarena
AU  - Zaragoza, Carlos
AU  - Zamorano Gómez, José Luis
PY  - 2020
DO  - 10.3390/biom10081167
UR  - https://hdl.handle.net/20.500.14352/113569
T2  - Biomolecules
AB  - Toll-like receptor 4 (TLR4) contributes to the pathogenesis of coronary ischemia/reperfusion (IR). To test whether the new TLR4 antagonist, ApTOLL, may prevent coronary IR damage, we administered 0.078 mg/kg ApTOLL or Placebo in pigs subjected to IR,...
LA  - eng
PB  - MDPI
KW  - ApTOLL
KW  - Acute myocardial infarction
KW  - Cytokines
KW  - Matrix metalloproteinases
KW  - Toll-like receptor 4
TI  - Targeting TLR4 with ApTOLL Improves Heart Function in Response to Coronary Ischemia Reperfusion in Pigs Undergoing Acute Myocardial Infarction
TY  - journal article
VL  - 10
ER  -